Warner-Lambert Canada Inc. et al. v. Canada (Minister of Health) et al., (2002) 296 N.R. 279 (FCA)
Linked as:
Extract
Warner-Lambert Canada Inc. et al. v. Canada (Minister of Health) et al., (2002) 296 N.R. 279 (FCA)
No longer available (Autolink)
See the full content of this document
This document cites
- Apotex Inc. v. Canada (Minister of National Health and Welfare) et al., (1997) 219 N.R. 151 (FCA)
- Glaxo Group Ltd. et al. v. Canada (Minister of National Health and Welfare) et al., 2001 FCA 96
- Warner-Lambert Canada Inc. et al. v. Canada (Minister of Health) et al., (2001) 210 F.T.R. 265 (TD)
- Bell ExpressVu Limited Partnership v. Rex et al., (2002) 287 N.R. 248 (SCC)
- Merck Frosst Canada Inc. et al. v. Canada (Minister of National Health and Welfare) et al., (1998) 227 N.R. 299 (SCC)
